SIRT1 and myeloid sarcoma: As reviewed by Piacente et al., sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2), which are NAD+-dependent deacetylases, possibly play a role in regulating neuroinflammation and microglial activation in MS [153].